-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Oj2dOj6omlkSr+brEoUgUS/RqAokr7V77FO64O8NQddXVngpaV3Xm/BV/MxN+Zk0 wxXS9ToxlS8kXYKqen8E3w== 0000946486-07-000031.txt : 20070625 0000946486-07-000031.hdr.sgml : 20070625 20070625121440 ACCESSION NUMBER: 0000946486-07-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070621 FILED AS OF DATE: 20070625 DATE AS OF CHANGE: 20070625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 BUSINESS PHONE: 2154889300 MAIL ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COOPER JOHN G CENTRAL INDEX KEY: 0001164287 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26422 FILM NUMBER: 07938105 MAIL ADDRESS: STREET 1: 350 SOUTH MAIN STREET, SUITE 307 CITY: DOYLESTOWN STATE: PA ZIP: 18901 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-06-21 0 0000946486 DISCOVERY LABORATORIES INC /DE/ DSCO 0001164287 COOPER JOHN G 2600 KELLY ROAD WARRINGTON PA 18976 0 1 0 0 Exec. VP, CFO Common Stock 2007-03-31 5 A 0 812 2.31 A 50006 D Incentive Stock Option (right to buy) 3.27 2007-06-21 4 A 0 30582 0 A 2010-06-21 2017-06-21 Common Stock 30582 30582 D Non-Qualified Stock Option (right to buy) 3.27 2007-06-21 4 A 0 129418 0 A 2007-06-21 2017-06-21 Common Stock 129418 129418 D Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan. This employee stock option shall vest 25% on the date of the grant, and the balance shall vest in a series of three successive equal annual installments beginning with the first year anniversary of the grant. John Cooper 2007-06-25 -----END PRIVACY-ENHANCED MESSAGE-----